Your Recent Quotes: 0 | 0

GlaxoSmithKline PLC

Related Information and Financials
Price Glossary Definition
48.66
0.23%
7/23/08 4:03
Open
48.39
Prev Close
48.55
Volume
506,500
52 Wk. Range
41-55
Year-to-Date Performance Glossary Definition
Latest Dividend
Dividend
0.52
Yield
4.48
Ex-Date
04/30/2008
Price/Earnings Comparisons Glossary Definition
 
16.63
 
13.50
 
17.50
GSK
Sect. Av.
S&P 500
Market Cap
127,342,110,600
Outstanding Shares
5,397,786,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy GSK Rating Report
Target Price (1Yr)
High
57.00
Revenue
46.82B

Annual Dividend
Rate
2.07
Yield
4.30
Growth
12 Month
3 Year
CAGR
Revenue
-0.90
0.16
0.05
Net Income
-1.90
0.25
0.08
EPS
0.50
0.30
0.09

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
11.02
-7.56
4.41
Earnings Per Share($)

12/2005
 
 
 
3.00
12/2006
 
 
 
3.74
12/2007
 
 
 
3.75

Earnings
EBITDA
16.83B
Revenue
45.09B
Outside Analyst Rating History

7/24/08
3
Buy
7/24/08
3
Hold
7/24/08
4
Sell

Jim Cramer Portfolio
Find out now if GSK is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
  • S&P 500 (SPX.X)
  • Dow Jones (INDU)
  • Nasdaq (COMPX)
    Latest Headlines
    GlaxoSmithLline upgraded; AU Optronics, LG Display, MPS Group and Coca-Cola Enterprises downgraded.

    7:19AM 07/24/08

    Intuitive Surgical soars on an earnings beat.

    4:43PM 07/23/08

    The major averages, which had been bobbing around the baseline, got an afternoon lift following the release of the Fed's beige book and a drop in oil prices.

    2:59PM 07/23/08

    The major averages are trading off their highs and bobbing around the baseline as traders digest another round of corporate earnings and another decline in oil prices ahead of the Fed's beige book.

    12:23PM 07/23/08

    Synta's chances with elesclomal, Vanda's chances with Fanapta, the Immunogen-Genentech connect, and more.

    11:07AM 07/18/08

    The biotech took a hit to shares after its mixed-bag earnings report, and that's created a nice discounted buying opportunity in shares.

    9:45AM 07/18/08

    Sequenom trades higher on an analyst upgrade.

    4:22PM 07/14/08

    Insmed climbs on study results.

    6:24PM 07/10/08

    Teva falls on trial results for higher-dose Copaxone, and APP Pharma surges on buyout news.

    3:51PM 07/07/08

    Abbott climbs on an FDA approval of its Xience V stent.

    12:42PM 07/03/08

    Understanding the Market

    Our Experts' Take at RealMoney
    Today's strong action should lead to more upside in this leading biotech stock.

    3:48PM 07/23/08

    The very stocks that had been most heavily shorted are rallying the hardest.

    11:47AM 07/23/08

    More Experts' Takes


    Premium Stock Ideas
    Is Cramer trading GSK in his Action Alerts Plus Portfolio?